Kathryn Phillips, PhD
Professor
Clinical Pharmacy
School of Pharmacy
kathryn.phillips@ucsf.edu 415-502-8271
Kathryn A. Phillips, PhD, is Professor of Health Economics and Health Services Research in the Department of Clinical Pharmacy at UCSF. A leader in the application of new technologies to improve healthcare, she is the Founding Director of the UCSF Center for Translational and Policy Research on Precision Medicine (TRANSPERS). She is a core faculty member in the UCSF Philip R.
Show full bio (660 words) Hide full bio
Lee Institute for Health Policy Studies and UCSF Helen Diller Family Comprehensive Cancer Center, and is affiliated with the Institute for Human Genetics, Department of Epidemiology and Biostatistics, Baker Computational Health Sciences Institute, and Global Health Sciences. She is the Founding Editor-in-Chief, Health Affairs Scholar: Emerging and Global Health Policy.
Kathryn focuses on the value of new technologies and how to most effectively and efficiently implement them into health care. Her core specialty is precision medicine — a new era of healthcare where medical interventions can be tailored to individual patients based on their unique genetic make-up. Her work spans multiple disciplines, including basic, clinical and social sciences, and brings together leading experts in academia, industry, healthcare, payers, and government. Her pioneering research on the application of health services research to personalized medicine has revealed insights on how to bridge the gap between emerging technologies and their use in the clinic. Kathryn led one of the earliest studies on the societal implications of pharmacogenomics, underscoring its potential to reduce the incidence of adverse drug reactions (JAMA, 2001). Kathryn has also conducted seminal work on HIV, as her analysis of HIV home testing informed the FDA’s decision to approve the first home collection HIV test (New England Journal of Medicine, 1995).
Kathryn has published ~200 peer-reviewed articles in major journals including JAMA, New England Journal of Medicine, Science, and Health Affairs and has been repeatedly named as being in the top 2% of authors for career-long citations in her field and in the top 100,000 of all researchers (Baas, 2021; Ioannidis 2020). She has had continuous funding from NIH as a Principal Investigator for 3 decades and was awarded a 5-year, $5M NIH grant to examine payer coverage and economic value for emerging genomic technologies. Kathryn serves on the editorial boards for Health Affairs and Value in Health and previously for JAMA Internal Medicine. She is a member of the National Academy of Medicine Roundtable on Genomics and Precision Health and served on a National Academy of Medicine consensus committee (2024-2025); and has served on the governing Board of Directors for GenomeCanada and as an advisor to the FDA, CDC, President’s Council of Advisors on Science and Technology, and the White House Office of Science and Technology. She has also served as an advisor to many diagnostics, sequencing, and pharmaceutical companies as well as venture capitalists. Kathryn is Chair of the Global Economics and Evaluation of Clinical Sequencing Working Group, and a member of one of the three evidence review committees for the Institute for Clinical and Economic Review (ICER). Her work has been quoted by the Washington Post, Wall Street Journal, New York Times, CNBC, Reuters, Newsweek, and other major news outlets.
Disclosures: Current ICER: Dr. Phillips receives honoraria from the California Technology Assessment Forum (CTAF), which is an independent appraisal committee for the Institute for Clinical and Economic Review (ICER).
Illumina, Inc.: Dr. Phillips receives consulting from Illumina for support of the Global Economics and Evaluation of Clinical Genomics Sequencing Working Group (https://www.geecsecon.org/).
Disclosures: Completed in past 3 years Precision Health Research, Singapore (PRECISE). Dr. Phillips is a member of the Health Economist Expert Network for PRECISE. PRECISE is a central entity set up to coordinate the government effort to implement Phase II of Singapore's 10-year National Precision Medicine strategy. (ended 2022)
Philips Healthcare. Dr Phillips was a member of a one-time meeting of the North American Oncology Advisory Community. Philips Healthcare provides healthcare solutions for diagnostic, treatment, and preventive care. (ended 2021)
Avia Health. Dr. Phillips was a consultant to Avia Health, which focuses on digital transformation to improve patient outcomes, streamline processes, and reduce costs. (ended 2022)
Association of Community Cancer Centers. Dr. Phillips served on the ACCC policy advisory board (ended 2021)
DeciBio Consulting. Dr Phillips served on a one-time advisory board on mult-cancer early detection tests (2021)
Roche Diagnostics. Dr. Phillips provided a one-time review of a clinical genomic profiling evidence assessment tool (2021)
Awards
Show all (10) Hide
- Standing Member of National Academy of Medicine Roundtable on Genomics and Precision Medicine, National Academy of Medicine, 2021
- Named in top 2% of authors for career-long citations in field and in top 100,000 of all researchers, Ioannidis et al, PlosBiology 2020; Baas et al,Mendeley Data 2021, 2020-2021
- Dean's Awards For Outstanding Teaching (multiple), UCSF, 2019-2021
- Honorary Lectureship, University of British Columbia, 2018
- Honorary Lectureship, U of Maryland, 2017
- Rockefeller Foundation Residency, Bellagio Center Italy, 2016
- Most cited article award, Research Triangle Institute, 2010
- 50 Most Cited HIV Behavioral Researchers in Past Decade, Univ of CT, 2003
- Article in New England Journal of Medicine contributed to FDA decision to approve home HIV test, 1996
- UC Berkeley Graduate Fellowship, UC Berkeley, 1987-1988
Education & Training
Show all (5) Hide
- Diversity, Equity, and Inclusion Champion Training University of California 10/2022
- Post-doctoral fellowship University of California 1993
- PhD Policy Analysis and Health Economics University of California 1991
- MPA Public Administration Kennedy School of Government Harvard University
- BA Psychology with High Honors University of Texas
Interests
Show all (17) Hide
- creating a high value health care system
- systematic literature review
- cancer
- health economics
- policy analysis
- Economic evaluation
- big data
- personalized/precision medicine
- cost-effectiveness analysis
- coverage/reimbursement policies
- secondary dataset analysis
- Insurer coverage
- utilization and cost-effectiveness of care
- population screening
- Health services research
- comparative effectiveness research
- value of diagnostics
Websites
Show all (4) Hide
- Posts on X KathrynP_phd (X.com)
- Global Economics and Evaluation of Clinical Genomics Sequencing Working Group (geecsecon.org)
- TRANSPERS Center (pharm.ucsf.edu)
- Health Affairs Podcast on Coverage for Emerging Cancer Screening Tests (healthaffairs.org)
Videos
Show all (6) Hide
- KPIX CBS news interview on Medicare coverage for Alzheimer's Drugs 2022 (youtube.com)
- Platform Talk American College Medical Genetics 2021 (youtube.com)
- Preview of plenary talk AGBT Precision Medicine conference 2021 (youtube.com)
- Stanford MedX presentation 2017 (youtube.com)
- illustrative presentation 2014 (youtube.com)
- faculty profile 2012 (youtube.com)
Grants and Projects
Show all (9) Hide
- Building the Evidence Base for Appropriate and Efficient Implementation of Emerging Genomic Tests for Disease Management and Screening, NIH, 2021-2026
- Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions, NIH, 2018-2021
- Risk-Benefit Trade-Offs for Whole Genome Sequencing, NIH, 2013-2019
- Personalized Medicine for Colorectal and Breast Cancer, NIH, 2008-2013
- Screening for Colorectal Cancer: An Integrated Approach, NIH, 2004-2009
- Use of Cancer Screening in a Managed Care Environment, NIH, 2000-2004
- Utilization and Cost Effectiveness of New Hiv Tests, NIH, 1999-2003
- Effectiveness and Cost-effectiveness of Hiv Testing, NIH, 1993-1999
- Government Intervention and Utilization of Hiv Screening, NIH, 1990-1991
Publications (129)
Top publication keywords:
Technology Assessment, BiomedicalGenomicsCost-Benefit AnalysisInsurance CarriersHealth ExpendituresMedicareCirculating Tumor DNAPrecision MedicineNeoplasmsInsurance CoverageHealth PolicyInsurance, Health, ReimbursementHigh-Throughput Nucleotide SequencingGenetic TestingExome
-
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework.
Applied health economics and health policy 2025 Smith HS, Regier DA, Goranitis I, Bourke M, IJzerman MJ, Degeling K, Montgomery T, Phillips KA, Wordsworth S, Buchanan J, Marshall DA -
Corrigendum to "Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests" [Healthcare 11 (2023) 100705].
Healthcare (Amsterdam, Netherlands) 2024 Lin GA, Phillips KA, Fendrick AM -
Payer Coverage Considerations for Alzheimer Disease Blood-Based Biomarker Tests.
JAMA 2024 Deverka PA, Lin GA, Phillips KA -
Open Access Publication at a Crossroads-Implications for Researchers and Beyond.
JAMA health forum 2024 Phillips KA -
State Biomarker Testing Insurance Coverage Laws-Reply.
JAMA 2024 Lin GA, Coffman JM, Phillips KA
Show all (124 more) Hide
-
Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis.
Molecular diagnosis & therapy 2024 Chen C, Douglas MP, Ragavan MV, Phillips KA, Jansen JP -
The State of State Biomarker Testing Insurance Coverage Laws.
JAMA 2024 Lin GA, Coffman JM, Phillips KA -
Paving the path for implementation of clinical genomic sequencing globally: Are we ready?
Health affairs scholar 2024 Marshall DA, Hua N, Buchanan J, Christensen KD, Frederix GWJ, Goranitis I, Ijzerman M, Jansen JP, Lavelle TA, Regier DA, Smith HS, Ungar WJ, Weymann D, Wordsworth S, Phillips KA -
Six months, strong impact.
Health affairs scholar 2024 Phillips KA -
Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis.
medRxiv : the preprint server for health sciences 2023 Chen C, Douglas MP, Ragavan MV, Phillips KA, Jansen JP -
The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2023 Jansen JP, Ragavan MV, Chen C, Douglas MP, Phillips KA -
Reading the crystal ball: Primary care implications while awaiting outcomes for multi-cancer early detection tests.
Healthcare (Amsterdam, Netherlands) 2023 Lin GA, Phillips KA, Fendrick AM -
Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy.
Health affairs scholar 2023 Trosman JR, Weldon CB, Kurian AW, Pasquinelli MM, Kircher SM, Martin N, Douglas MP, Phillips KA -
Ten health policy challenges for the next 10 years.
Health affairs scholar 2023 Phillips KA, Marshall DA, Adler L, Figueroa J, Haeder SF, Hamad R, Hernandez I, Moucheraud C, Nikpay S -
Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment.
Journal of the National Comprehensive Cancer Network : JNCCN 2023 Douglas MP, Ragavan MV, Chen C, Kumar A, Gray SW, Blakely CM, Phillips KA -
CMS Coverage With Evidence Development-Challenges and Opportunities for Improvement.
JAMA health forum 2022 Phillips KA -
Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.
Journal of genetic counseling 2022 Weldon CB, Trosman JR, Liang SY, Douglas MP, Scheuner MT, Kurian A, Schaa KL, Roscow B, Erwin D, Phillips KA -
Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access.
Health affairs (Project Hope) 2022 Deverka PA, Douglas MP, Phillips KA -
Geriatricians' Perspectives on the Multiple Dimensions of Utility of Genetic Testing for Alzheimer's Disease: A Qualitative Study.
Journal of Alzheimer's disease : JAD 2022 Arias JJ, Lin GA, Tyler AM, Douglas MP, Phillips KA -
US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).
Genetics in medicine : official journal of the American College of Medical Genetics 2021 Phillips KA, Trosman JR, Douglas MP, Gelb BD, Ferket BS, Hindorff LA, Slavotinek AM, Berg JS, Russell HV, Devine B, Greve V, Smith HS -
Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants.
Journal of community genetics 2021 Douglas MP, Lin GA, Trosman JR, Phillips KA -
Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.
Journal of genetic counseling 2021 Lin GA, Trosman JR, Douglas MP, Weldon CB, Scheuner MT, Kurian A, Phillips KA -
Developing an Economic and Policy Research Agenda for Blood Biomarkers of Neurodegenerative Diseases.
JAMA health forum 2021 Arias JJ, Phillips KA, Karlawish J -
Laboratory business models and practices: implications for availability and access to germline genetic testing.
Genetics in medicine : official journal of the American College of Medical Genetics 2021 Scheuner MT, Douglas MP, Sales P, Ackerman SL, Phillips KA -
Availability and funding of clinical genomic sequencing globally.
BMJ global health 2021 Phillips KA, Douglas MP, Wordsworth S, Buchanan J, Marshall DA -
Private payer coverage policies for ApoE-e4 genetic testing.
Genetics in medicine : official journal of the American College of Medical Genetics 2021 Arias JJ, Tyler AM, Douglas MP, Phillips KA -
Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation.
JAMA 2020 Phillips KA, Douglas MP, Marshall DA -
Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019.
Journal of the National Comprehensive Cancer Network : JNCCN 2020 Douglas MP, Gray SW, Phillips KA -
Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Phillips KA -
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Marshall DA, Grazziotin LR, Regier DA, Wordsworth S, Buchanan J, Phillips K, Ijzerman M -
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Deverka PA, Douglas MP, Phillips KA -
Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Mackay ZP, Dukhovny D, Phillips KA, Beggs AH, Green RC, Parad RB, Christensen KD, BabySeq Project Team -
Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Trosman JR, Douglas MP, Liang SY, Weldon CB, Kurian AW, Kelley RK, Phillips KA -
Can precision medicine help achieve the goal of reducing care when the risks exceed the benefits?
Personalized medicine 2019 Phillips KA, Marshall DA, Kurian AW -
Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).
Genetics in medicine : official journal of the American College of Medical Genetics 2019 Trosman JR, Weldon CB, Slavotinek A, Norton ME, Douglas MP, Phillips KA -
Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs.
JAMA 2019 Phillips KA, Trosman JR, Douglas MP -
A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service.
Journal of the American College of Clinical Pharmacy : JACCP 2018 Zakinova A, Long-Boyle JR, French D, Croci R, Wilson L, Phillips KA, Kroetz DL, Shin J, Tamraz B -
The Global Market for Next-Generation Sequencing Tests Continues Its Torrid Pace.
The Journal of precision medicine 2018 Phillips KA, Douglas MP -
Assessing the Value of Next-Generation Sequencing Technologies: An Introduction.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2018 Phillips KA -
Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2018 Christensen KD, Phillips KA, Green RC, Dukhovny D -
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2018 Phillips KA, Deverka PA, Marshall DA, Wordsworth S, Regier DA, Christensen KD, Buchanan J -
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2018 Trosman JR, Weldon CB, Gradishar WJ, Benson AB, Cristofanilli M, Kurian AW, Ford JM, Balch A, Watkins J, Phillips KA -
Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Douglas MP, Parker SL, Trosman JR, Slavotinek AM, Phillips KA -
Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?
JAMA 2018 Phillips KA -
Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
Health affairs (Project Hope) 2018 Phillips KA, Deverka PA, Hooker GW, Douglas MP -
Precision Medicine: From Science To Value.
Health affairs (Project Hope) 2018 Ginsburg GS, Phillips KA -
Insurance coverage for genomic tests.
Science (New York, N.Y.) 2018 Phillips KA, Trosman JR, Deverka PA, Quinn B, Tunis S, Neumann PJ, Chambers JD, Garrison LP, Douglas MP, Weldon CB -
Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Christensen KD, Vassy JL, Phillips KA, Blout CL, Azzariti DR, Lu CY, Robinson JO, Lee K, Douglas MP, Yeh JM, Machini K, Stout NK, Rehm HL, McGuire AL, Green RC, Dukhovny D, MedSeq Project -
Corrigendum: What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Genetics in medicine : official journal of the American College of Medical Genetics 2017 Marshall DA, Gonzalez JM, Johnson FR, MacDonald KV, Pugh A, Douglas MP, Phillips KA -
EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.
International journal of technology assessment in health care 2017 Chambers JD, Saret CJ, Anderson JE, Deverka PA, Douglas MP, Phillips KA -
Payer coverage policies for multigene tests.
Nature biotechnology 2017 Phillips KA, Deverka PA, Trosman JR, Douglas MP, Chambers JD, Weldon CB, Dervan AP -
The price of whole-genome sequencing may be decreasing, but who will be sequenced?
Personalized medicine 2017 Marshall DA, MacDonald KV, Robinson JO, Barcellos LF, Gianfrancesco M, Helm M, McGuire A, Green RC, Douglas MP, Goldman MA, Phillips KA -
Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research.
Genetics in medicine : official journal of the American College of Medical Genetics 2017 Phillips KA, Deverka PA, Sox HC, Khoury MJ, Sandy LG, Ginsburg GS, Tunis SR, Orlando LA, Douglas MP -
Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
Journal of the National Comprehensive Cancer Network : JNCCN 2017 Trosman JR, Weldon CB, Douglas MP, Kurian AW, Kelley RK, Deverka PA, Phillips KA -
"What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Phillips KA, Douglas MP, Trosman JR, Marshall DA -
Assessing the Value and Implications of Personalized/Precision Medicine and the "Lessons Learned" for Emerging Technologies: An Introduction.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Phillips KA -
Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Trosman JR, Weldon CB, Douglas MP, Deverka PA, Watkins JB, Phillips KA -
Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.
Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dervan AP, Deverka PA, Trosman JR, Weldon CB, Douglas MP, Phillips KA -
What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Genetics in medicine : official journal of the American College of Medical Genetics 2016 Marshall DA, Gonzalez JM, Johnson FR, MacDonald KV, Pugh A, Douglas MP, Phillips KA -
Most Americans Do Not Believe That There Is An Association Between Health Care Prices And Quality Of Care.
Health affairs (Project Hope) 2016 Phillips KA, Schleifer D, Hagelskamp C -
Availability and payer coverage of BRCA1/2 tests and gene panels.
Nature biotechnology 2015 Clain E, Trosman JR, Douglas MP, Weldon CB, Phillips KA -
Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.
Genetics in medicine : official journal of the American College of Medical Genetics 2015 Douglas MP, Ladabaum U, Pletcher MJ, Marshall DA, Phillips KA -
Key emerging themes for assessing the cost-effectiveness of reporting incidental findings.
Genetics in medicine : official journal of the American College of Medical Genetics 2015 Phillips KA, Ladabaum U, Pletcher MJ, Marshall DA, Douglas MP -
Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.
Journal of the National Comprehensive Cancer Network : JNCCN 2015 Trosman JR, Weldon CB, Kelley RK, Phillips KA -
Potential public sector cost-savings from over-the-counter access to oral contraceptives.
Contraception 2015 Foster DG, Biggs MA, Phillips KA, Grindlay K, Grossman D -
Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample.
Medical decision making : an international journal of the Society for Medical Decision Making 2015 Knight SJ, Mohamed AF, Marshall DA, Ladabaum U, Phillips KA, Walsh JM -
Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology.
Personalized medicine 2015 Garfeld S, Douglas MP, MacDonald KV, Marshall DA, Phillips KA -
Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing.
Technology and health care : official journal of the European Society for Engineering and Medicine 2015 Phillips KA, Pletcher MJ, Ladabaum U -
Genomic sequencing: assessing the health care system, policy, and big-data implications.
Health affairs (Project Hope) 2014 Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB -
Prostatitis, steatitis, and diarrhea in a dog following presumptive flea-borne transmission of Bartonella henselae.
Journal of clinical microbiology 2014 Balakrishnan N, Pritchard J, Ericson M, Grindem C, Phillips K, Jennings S, Mathews K, Tran H, Birkenheuer AJ, Breitschwerdt EB -
The economic value of personalized medicine tests: what we know and what we need to know.
Genetics in medicine : official journal of the American College of Medical Genetics 2013 Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P -
Economic Perspectives on Personalized Health Care and Prevention.
Forum for health economics & policy 2013 Phillips KA, Sakowski JA, Liang SY, Ponce NA -
Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome.
Journal of oncology practice 2012 Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U -
Differences in US healthcare coverage policies in BRCA testing and potential implications.
Personalized medicine 2012 Beattie MS, Wang G, Phillips KA -
Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling.
Genetics in medicine : official journal of the American College of Medical Genetics 2011 Wang G, Beattie MS, Ponce NA, Phillips KA -
Economic evaluation of targeted cancer interventions: critical review and recommendations.
Genetics in medicine : official journal of the American College of Medical Genetics 2011 Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA -
Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer.
Medical care 2011 Liang SY, Phillips KA, Wang G, Keohane C, Armstrong J, Morris WM, Haas JS -
Genomic testing and therapies for breast cancer in clinical practice.
Journal of oncology practice 2011 Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M -
Health technology assessment and private payers' coverage of personalized medicine.
Journal of oncology practice 2011 Trosman JR, Van Bebber SL, Phillips KA -
Health technology assessment and private payers's coverage of personalized medicine.
The American journal of managed care 2011 Trosman JR, Van Bebber SL, Phillips KA -
How does cost matter in health-care discrete-choice experiments?
Health economics 2011 Johnson FR, Mohamed AF, Ozdemir S, Marshall DA, Phillips KA -
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2011 Kelley RK, Van Bebber SL, Phillips KA, Venook AP -
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.
Journal of oncology practice 2010 Trosman JR, Van Bebber SL, Phillips KA -
Capacity building for assessing new technologies: approaches to examining personalized medicine in practice.
Personalized medicine 2010 Van Bebber SL, Trosman JR, Liang SY, Wang G, Marshall DA, Knight S, Phillips KA -
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.
Health economics 2009 Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van Bebber S, Phillips KA -
Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients.
Cancer 2009 Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL -
Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses.
Personalized medicine 2009 Ferrusi IL, Marshall DA, Kulin NA, Leighl NB, Phillips KA -
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.
Current opinion in molecular therapeutics 2008 Phillips KA, Liang SY, Van Bebber S, Canpers Research Group -
Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening.
Preventing chronic disease 2007 Haas JS, Fitzmaurice G, Brawarsky P, Liang SY, Hiatt RA, Klabunde CN, Brown ML, Phillips KA -
Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends.
Current drug safety 2007 Issa AM, Phillips KA, Van Bebber S, Nidamarthy HG, Lasser KE, Haas JS, Alldredge BK, Wachter RM, Bates DW -
Measuring patient preferences for colorectal cancer screening using a choice-format survey.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007 Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA -
Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk.
Personalized medicine 2007 Van Bebber SL, Liang SY, Phillips KA, Marshall D, Walsh J, Kulin N -
Trends in colonoscopy for colorectal cancer screening.
Medical care 2007 Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL -
Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings.
Contraception 2006 Afable-Munsuz A, Gould H, Stewart F, Phillips KA, Van Bebber SL, Moore C -
Initial development of an evidence base for personalized medicine's translation to clinical practice and health policy.
Personalized medicine 2006 Phillips KA, Van Bebber SL, Issa AM -
Innovation in personalized medicine: BiDil® as a case study for integrating clinical and policy developments.
Personalized medicine 2006 Issa AM, Todd Weiss L, Tufail W, Phillips KA, Van Bebber SL -
Novel personalized medicine technology: UGT1A1 testing for irinotecan as a case study.
Personalized medicine 2006 Van Bebber SL, Keegan HL, Phillips KA, Issa AM -
Rates and predictors of colorectal cancer screening.
Preventing chronic disease 2006 Liang SY, Phillips KA, Nagamine M, Ladabaum U, Haas JS -
Biotechnology and Medicare's new technology policy: lessons from three case studies.
Health affairs (Project Hope) 2006 Keenan PS, Neumann PJ, Phillips KA -
The intersection of biotechnology and pharmacogenomics: health policy implications.
Health affairs (Project Hope) 2006 Phillips KA -
A review of studies examining stated preferences for cancer screening.
Preventing chronic disease 2006 Phillips KA, Van Bebber S, Marshall D, Walsh J, Thabane L -
Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration.
Medical care research and review : MCRR 2006 Phillips KA, Van Bebber SL -
Diagnostics and biomarker development: priming the pipeline.
Nature reviews. Drug discovery 2006 Phillips KA, Van Bebber S, Issa AM -
How the new medicare drug benefit could affect vulnerable populations.
Health affairs (Project Hope) 2006 Gellad WF, Huskamp HA, Phillips KA, Haas JS -
Patient costs for medication abortion: results from a study of five clinical practices.
Women's health issues : official publication of the Jacobs Institute of Women's Health 2006 Van Bebber SL, Phillips KA, Weitz TA, Gould H, Stewart F -
Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases.
Heart rhythm 2005 Phillips KA, Ackerman MJ, Sakowski J, Berul CI -
Prescription drug dispensing limits and patterns.
Managed care interface 2005 Phillips KA, Liang SY, Haas JS, Stebbins M, Alldredge BK -
Measuring the value of pharmacogenomics.
Nature reviews. Drug discovery 2005 Phillips KA, Van Bebber SL -
A systematic review of cost-effectiveness analyses of pharmacogenomic interventions.
Pharmacogenomics 2004 Phillips KA, Van Bebber SL -
The effect of area HMO market share on cancer screening.
Health services research 2004 Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D -
Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States).
Cancer causes & control : CCC 2004 Haggstrom DA, Phillips KA, Liang SY, Haas JS, Tye S, Kerlikowske K -
Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs.
The American journal of managed care 2004 Phillips KA, Veenstra DL, Ramsey SD, Van Bebber SL, Sakowski J -
Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence.
Medical care 2004 Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Baker LC, Kaplan CP, Pérez-Stable EJ, Liang SY -
Are gatekeeper requirements associated with cancer screening utilization?
Health services research 2004 Phillips KA, Haas JS, Liang SY, Baker LC, Tye S, Kerlikowske K, Sakowski J, Spetz J -
Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services.
The American journal of managed care 2004 Liang SY, Phillips KA, Tye S, Haas JS, Sakowski J -
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography.
Health services research 2004 Tye S, Phillips KA, Liang SY, Haas JS -
Out-of-pocket expenditures for oral contraceptives and number of packs per purchase.
Journal of the American Medical Women's Association (1972) 2004 Phillips KA, Stotland NE, Liang SY, Spetz J, Haas JS, Oren E -
The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents.
American journal of public health 2003 Haas JS, Lee LB, Kaplan CP, Sonneborn D, Phillips KA, Liang SY -
Important step forward in HIV-testing technologies [correction of technolgies].
American journal of preventive medicine 2003 Phillips KA -
An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics.
Pharmacogenomics 2003 Phillips KA, Veenstra D, Van Bebber S, Sakowski J -
Is the prevalence of gatekeeping in a community associated with individual trust in medical care?
Medical care 2003 Haas JS, Phillips KA, Baker LC, Sonneborn D, McCulloch CE -
Willingness to use instant home HIV tests: data from the California Behavioral Risk Factor Surveillance Survey.
American journal of preventive medicine 2003 Phillips KA, Chen JL -
New Centers for Disease Control and Prevention's guidelines on HIV counseling and testing for the general population and pregnant women.
Journal of acquired immune deficiency syndromes (1999) 2003 Phillips KA, Bayer R, Chen JL -
Viagra and contraceptives.
Health affairs (Project Hope) 2003 Phillips KA, Spetz J, Haas JS -
Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.
Health services research 2002 Phillips KA, Maddala T, Johnson FR -
Measuring what people value: a comparison of "attitude" and "preference" surveys.
Health services research 2002 Phillips KA, Johnson FR, Maddala T -
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States.
Medical care 2002 Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Liang SY -
Evaluating the potential impact of pharmacogenomics on ADRs.
Journal of managed care pharmacy : JMCP 2002 Oren E, McCart G, Phillips KA -
Impact of the U.S. panel on cost-effectiveness in health and medicine.
American journal of preventive medicine 2002 Phillips KA, Chen JL